• Register
  • Login
  • Subscribe
  • Contact Us

Dgc - Supply of Injectable Oncological Medicines Ii

ChileTenders notice for Dgc - Supply of Injectable Oncological Medicines Ii. The reference ID of the tender is 124432310 and it is closing on 01 Sep 2025.

Tender Details

  • Country: Chile
  • Summary: Dgc - Supply of Injectable Oncological Medicines Ii
  • CLT Ref No: 124432310
  • Deadline: 01 Sep 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 1641-319-LP25
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • The object of this tender is the acquisition of the supply of injectable oncological medicines II according to the following detail: Item Code Description Unit of measure required 1 01-001-219-0185 Iphosphamide 2 g Polv liof FA FLASK AMPOLLA 1920 2 01-001-219-020 Idarrubicin 10 MG FA FLASK AMPOLLA 360 3 01-001-219-017 BLEOMYCIN 15 IU FA FLASK AMPOLLA 1200 at the time of awarding, the hospital may increase or decrease up to 30% of the amounts estimated in these bidding bases, according to the available budgets, and without altering the principle of strict subjection to the basis of equality of the bidders. (*) It is recorded that the amounts of products or services are variable flow, not compromising the hospital to acquire certain amounts periodically, so in no case will be set for a minimum purchase stock, in Nor total, so the winner or winners will be unable to indicate minimum amounts for their office. It is also in mind that this bidding process will be done by awarded item (line), so that each supplier can offer for an item of those indicated at this point, For more than one or all of them, corresponding each item to a product or service line. The offer through the public market platform must be made for net value (without VAT).
    Products or services: Ifosfamide, medication and pills dosing or acc...
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Dgc - Supply of Injectable Oncological Medicines Ii - Chile Tender

The HEALTH SERVICE OCCIDENTE SAN JUAN DE DIOS HOSPITAL, a Government sector organization in Chile, has announced a new tender for Dgc - Supply of Injectable Oncological Medicines Ii. This tender is published on ChileTenders under CLT Ref No: 124432310 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-01.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

ChileTenders Features

ChileTenders Features

Fresh and verified Tenders from Chile. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ChileTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Chile in your email inbox.

  Chat with us